These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 5960037)

  • 21. Hepatic morphology and iron quantitation in perinatal hemochromatosis. Comparison with a large perinatal control population, including cases with chronic liver disease.
    Silver MM; Valberg LS; Cutz E; Lines LD; Phillips MJ
    Am J Pathol; 1993 Nov; 143(5):1312-25. PubMed ID: 8238250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
    Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of postshunt hemochromatosis--parenchymal siderosis in patients with cirrhosis occuring after portasystemic shunt surgery. A review of the literature and report of two additional cases.
    Ecker JA; Gray PA; McKittrick JE; Dickson DR
    Am J Gastroenterol; 1968 Jul; 50(1):13-29. PubMed ID: 5662506
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
    Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
    J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood iron and blood copper in hepatic cirrhosis].
    Franquelo Villalonga E; González Gor R
    Rev Esp Enferm Apar Dig; 1977 Jun; 50(6):655-64. PubMed ID: 897316
    [No Abstract]   [Full Text] [Related]  

  • 26. [Liver cirrhosis with siderosis. II].
    Abad Alonso JA
    Rev Clin Esp; 1970 Feb; 116(4):319-26. PubMed ID: 4922359
    [No Abstract]   [Full Text] [Related]  

  • 27. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.
    Zeegen R; Drinkwater JE; Fenton JC; Vince A; Dawson AM
    Q J Med; 1970 Apr; 39(154):245-63. PubMed ID: 5449591
    [No Abstract]   [Full Text] [Related]  

  • 28. [Increase of appetite by Nuran in liver diseases].
    Hilt G; Bungeroth KA
    Munch Med Wochenschr; 1971 Jan; 113(3):91-4. PubMed ID: 5276193
    [No Abstract]   [Full Text] [Related]  

  • 29. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases.
    Wu TT; Levy M; Correa AM; Rosen CB; Abraham SC
    Cancer; 2009 Oct; 115(19):4564-75. PubMed ID: 19670455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hyperaldosteronism in acute viral hepatitis, liver cirrhosis and fulminating liver failure].
    Müller G; Spech HJ; Wellhöfer G; Wernze H; Wilkinson SP; Bernardi M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():436-9. PubMed ID: 1029233
    [No Abstract]   [Full Text] [Related]  

  • 31. The pathology of hepatic cirrhosis. A study of 70 biopsies and their clinical correlations.
    Correia JP; Baptista AS; Alves MP
    Acta Hepatosplenol; 1971; 18(6):470-81. PubMed ID: 5134147
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation between hepatosplenic and marrow iron in liver cirrhosis.
    Ali M; Fayemi AO; Braun EV; Malcolm D; Laraia S
    Arch Pathol Lab Med; 1982 Apr; 106(4):200-4. PubMed ID: 6279053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dark adaptation in patients with chronic liver diseases. 1. Disturbances in dark adaptation in patients with chronic liver].
    Klein S; Dökert B; Dressel H; Renger F
    Dtsch Gesundheitsw; 1971 May; 26(22):1027-30. PubMed ID: 5121726
    [No Abstract]   [Full Text] [Related]  

  • 35. Iron-containing nodules of cirrhosis.
    Zhang J; Krinsky GA
    NMR Biomed; 2004 Nov; 17(7):459-64. PubMed ID: 15526293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nutritional disorders in patients with chronic liver disease].
    Toigo G; Situlin R; Faccini L; Lipartiti T; Frezza M; Guarnieri GF; Crevatin M; Pierini B; Giglio I
    G Clin Med; 1982 Aug; 63(8):544-50. PubMed ID: 6818084
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic effects of vitamin A on light-dark adaptation disorders and color perception disorders in patients with chronic liver diseases].
    Klein S; Dökert B; Marré E; Renger F; Westermann K
    Z Gesamte Inn Med; 1974 Jun; 29(12):484-7. PubMed ID: 4849979
    [No Abstract]   [Full Text] [Related]  

  • 39. [Disorders of color vision in liver diseases].
    Dittrich H; Neubauer O
    Munch Med Wochenschr; 1967 Dec; 109(51):2690-3. PubMed ID: 5301769
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased duodenal expression of divalent metal transporter 1 and iron-regulated gene 1 in cirrhosis.
    Stuart KA; Anderson GJ; Frazer DM; Murphy TL; Powell LW; Fletcher LM; Crawford DH
    Hepatology; 2004 Feb; 39(2):492-9. PubMed ID: 14768003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.